about
Antiviral drugs for viruses other than human immunodeficiency virusRenal safety of a tenofovir-containing first line regimen: experience from an antiretroviral cohort in rural Lesotho.AtriplaR/anti-TB combination in TB/HIV patients. Drug in focusComparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV preventionPharmacologic perspectives for once-daily antiretroviral therapy.Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion.Simian immunodeficiency virus SIVagm dynamics in African green monkeys.An update and review of antiretroviral therapy.Innate immune defenses in HIV-1 infection: prospects for a novel immune therapy.Tenofovir for the treatment of hepatitis B virus.Clinical Outcomes of Tenofovir Versus Zidovudine-based Regimens Among People Living with HIV/AIDS: a Two Years Retrospective Cohort Study.Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.Acyclic nucleoside bisphosphonates: synthesis and properties of chiral 2-amino-4,6-bis[(phosphonomethoxy)alkoxy]pyrimidinesDesign and in vitro evaluation of tenofovir-loaded vaginal gels for the prevention of HIV infections.Formulation development and optimization of Lamivudine 300 mg and Tenofovir Disoproxil Fumarate (TDF) 300 mg FDC tablets by D-optimal mixture design.Intracellular Activation of Tenofovir Alafenamide and the Effect of Viral and Host Protease Inhibitors.Cathepsin A is the major hydrolase catalyzing the intracellular hydrolysis of the antiretroviral nucleotide phosphonoamidate prodrugs GS-7340 and GS-9131.Correction: tenofovir disoproxil fumarate.Hybrid magneto-plasmonic liposomes for multimodal image-guided and brain-targeted HIV treatment.Anti-DNA Virus Agents
P2860
Q24635330-E2E3A052-3238-40F4-BB99-8B22A67B6394Q33847019-83339E70-6D4C-4F3A-8776-A79E1C4C408CQ34083071-8972D7B9-C8BF-46F2-9E7B-5FB433F2C1D2Q34784522-B9C42262-4D81-4499-8479-8087C05A346CQ35915916-4B8812F8-45B0-4CF3-8DD2-2F359238C6C2Q36032477-903C8A9C-1A8F-4BCA-AB78-9546EADE6445Q36498208-622D053A-1630-4476-90A2-CD5FA198E2DAQ36545072-6A712902-2E79-4DDC-B21A-8B3C5445D26EQ36670882-8BEF7728-2A3C-48AD-92B3-9BA087988115Q37605886-C814073B-4601-4837-A891-8C218AB523AFQ37635145-9F1FF731-ACF8-4696-B40E-53EAE6C82324Q38038690-DE670EE0-3E6F-4767-B000-DE67079BEF4AQ39919863-62135D7C-9E99-4C22-BBB5-0B6CB2D5F82EQ40201612-BBBA5F3B-64A6-4C5A-8AD1-8BAA432BA1CBQ40413692-BFB1436D-51D7-4C60-9D8E-1CC92E1557C8Q41183595-DBF3ACD8-AD65-45D4-A57A-71CCB232AEBFQ41984465-EA4911F4-3104-4C89-ABC4-60C7D17F9306Q44501117-CAB6EDB0-33CD-4D8C-B544-D33D27278E26Q47568994-BDDE179B-89F4-4F4A-B032-6D8D9DD23C06Q56786267-14EE1EAD-0CB3-4294-99EA-C4E3C73D14A3
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Tenofovir disoproxil fumarate.
@ast
Tenofovir disoproxil fumarate.
@en
Tenofovir disoproxil fumarate.
@nl
type
label
Tenofovir disoproxil fumarate.
@ast
Tenofovir disoproxil fumarate.
@en
Tenofovir disoproxil fumarate.
@nl
prefLabel
Tenofovir disoproxil fumarate.
@ast
Tenofovir disoproxil fumarate.
@en
Tenofovir disoproxil fumarate.
@nl
P2860
P356
P1476
Tenofovir disoproxil fumarate.
@en
P2093
Frank Romanelli
Shellee A Grim
P2860
P304
P356
10.1345/APH.1C388
P407
P577
2003-06-01T00:00:00Z